Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Christopher Senner Insider Profile
11 Followers
Christopher Senner, EVP & CFO at Exelixis, holds 706.90K shares in Exelixis (Ticker: EXEL), holds ― shares in Quince Therapeutics (Ticker: QNCX).
Profitable Transactions
3 out of 5 Profitable Transactions
Average Return
-1.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Christopher Senner holds in companies
Most Profitable Insider Trade
The most profitable trade made by Christopher Senner
Christopher Senner's Trading History
Exelixis
Nov 19, 2024
EVP & CFO
Uninformative Sell
613.59K
$24.49M
Quince Therapeutics
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Christopher Senner's performance on stock
You May Also Like
Christopher Senner insider profile FAQ
What is the percentage of profitable transactions made by Christopher Senner?
The percentage of profitable transactions made by Christopher Senner is 60%.
What is the average return per transaction made by Christopher Senner?
The average return per transaction made by Christopher Senner is -1.20%.
What stocks does Christopher Senner hold?
Christopher Senner holds: EXEL, QNCX stocks.
What was Christopher Senner’s latest transaction?
Christopher Senner latest transaction was an Uninformative Sell of $613.59K.
What was Christopher Senner's most profitable transaction?
Christopher Senner’s most profitable transaction was an Informative Sell of EXEL stock on September 14, 2017. The return on the trade was 37.70%.
What is Christopher Senner's role in Exelixis?
Christopher Senner's role in Exelixis is EVP & CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.